Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension

Author： Stakkestad Jacob   Lakatos Peter   Lorenc Roman   Sedarati Farhad   Neate Colin   Reginster Jean-Yves  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.27, Iss.8, 2008-08, pp. : 955-960

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Changes in Cognitive Function over 3 Years after First-Ever Stroke and Predictors of Cognitive Impairment and Long-Term Cognitive Stability: The Erlangen Stroke Project

By  

Dementia and Geriatric Cognitive Disorders, Vol. 31, Iss. 4, 2011-04 ,pp. : 291-299

Karger

Access to resources Recommend Favorite

Once-Monthly Ibandronate

By Dando Toni M.   Noble Stuart  

Treatments in Endocrinology, Vol. 4, Iss. 6, 2005-01 ,pp. : 381-387

Adis International

Access to resources Recommend Favorite

Functional Outcome 3 Months after Stroke Predicts Long-Term Survival

By  

Cerebrovascular Diseases, Vol. 25, Iss. 5, 2008-03 ,pp. : 423-429

Karger

Access to resources Recommend Favorite

Long-Term Survival after Stroke: 30 Years of Follow-Up in a Cohort, the Copenhagen City Heart Study

By  

Neuroepidemiology, Vol. 33, Iss. 3, 2009-07 ,pp. : 254-260

Karger

Access to resources Recommend Favorite

Long-Term Effectiveness and Safety Outcomes in HIV-1-Infected Patients After a Median Time of 6 Years on Nevirapine

By  

Current HIV Research, Vol. 7, Iss. 5, 2009-09 ,pp. : 526-532

Bentham Science Publishers

Access to resources Recommend Favorite